Eli Lilly and Co., which cemented its place in Boston last year with the opening of a new research and development center, is now buying a cancer program from a Boston biotech. Eli Lilly and Co ...

Seaport, which is located on Tide Street in Boston’s Seaport District ... a former high-ranking executive at Eli Lilly and Company. Current treatments, he added, “provide inadequate relief ...

Eli Lilly and Company discovers ... Innovation Center (LSC), a research and development facility in the Boston Seaport to advancing Lilly's efforts in RNA and DNA-based therapies as well as ...

Eli Lilly and Company (NYSE ... The company also operates the Lilly Seaport Innovation Center in Boston, which focuses on RNA ...

As part of the proposed terms, Eli Lilly would pay Boston-based Scorpion about $1bn up front followed by up to $1.5bn at a later date if certain performance milestones were met, according to three ...